| Andrea L Bequest, PA | |
|
9200 W Wisconsin Ave, Internal Medicine, Milwaukee, WI 53226-3522 | |
| (414) 955-0350 | |
| (414) 805-6851 |
| Full Name | Andrea L Bequest |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 9200 W Wisconsin Ave, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003179839 | NPI | - | NPPES |
| 1003179839 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 2952-23 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Froedtert Memorial Lutheran Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Medical College Of Wisconsin Inc | 2668384371 | 1813 |
News Archive
Maria T. Lymberis, MD, a member of the Cooperative of American Physicians, Inc., will be honored with the 2014 Gary S. Nye Award for Physician Health and Well-Being for her longstanding commitment to physician health in her local community and in the state of California, as well as her career-long contributions to medical ethics.
Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus in liver and kidney transplant patients and everolimus in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the management of immunosuppressant drug therapy.
New research from the Hebrew University of Jerusalem shows that the most common form of white blood cells, called neutrophils, contain many different subtypes, of which some fight the development of cancer and others promote its progression. The research could help pave the way to new therapies that fight cancer by increasing anti-tumor neutrophils while limiting pro-tumor neutrophils.
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea L Bequest, PA 9200 W Wisconsin Ave, Internal Medicine, Milwaukee, WI 53226-3522 Ph: (414) 955-0350 | Andrea L Bequest, PA 9200 W Wisconsin Ave, Internal Medicine, Milwaukee, WI 53226-3522 Ph: (414) 955-0350 |
News Archive
Maria T. Lymberis, MD, a member of the Cooperative of American Physicians, Inc., will be honored with the 2014 Gary S. Nye Award for Physician Health and Well-Being for her longstanding commitment to physician health in her local community and in the state of California, as well as her career-long contributions to medical ethics.
Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus in liver and kidney transplant patients and everolimus in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the management of immunosuppressant drug therapy.
New research from the Hebrew University of Jerusalem shows that the most common form of white blood cells, called neutrophils, contain many different subtypes, of which some fight the development of cancer and others promote its progression. The research could help pave the way to new therapies that fight cancer by increasing anti-tumor neutrophils while limiting pro-tumor neutrophils.
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
› Verified 3 days ago
Amanda J Mueller, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Froedtert Hospital - East Clinics, Milwaukee, WI 53226 Phone: 414-955-6900 | |
Kelsey Kujellis, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2801 W Kinnickinnic River Pkwy Ste 777, Milwaukee, WI 53215 Phone: 414-649-3370 | |
Meredith Batzner, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-5400 Fax: 414-955-0115 | |
Claire Kathryn Choren, Physician Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-6400 | |
Mr. Steven P Kisch, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Department Of Neurosurgery, Milwaukee, WI 53226 Phone: 414-805-5400 Fax: 414-955-0115 | |
Kristin N Otero, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5000 W Chambers St, Milwaukee, WI 53210 Phone: 414-447-2000 |